ASLAN PHARMACEUTICALS ADR REP 5 (NASDAQ:ASLN) Receiving Somewhat Critical News Coverage, Study Finds

Author: Liza Goodheart

Published: Sept. 14, 2018, 8:03 p.m. ==> 2 months ago



Media stories about ASLAN PHARMACEUTICALS ADR REP 5 (NASDAQ:ASLN) have trended somewhat negative this week, according to Accern. The research firm ranks the sentiment of press coverage by monitoring more than 20 million news and blog sources. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one […]

More Info